Grady maintains a diverse commercial litigation practice. He advises clients in contract, fraud, shareholder, and employment disputes. He also counsels insurers in complex coverage matters and bad faith litigation. His experience includes drafting briefs, managing discovery, and taking and defending depositions.
Before joining Mintz, Grady was a litigation associate at a New York-based international law firm. Before that, Grady served as a law clerk for the Honorable Gustavo A. Gelpí, who is now Chief Judge of the United States District Court for the District of Puerto Rico.
During law school, Grady served as a judicial intern for the Honorable Patti B. Saris, Chief Judge of the United States District Court for the District of Massachusetts. In law school, Grady was an executive editor of the Alaska Law Review and a student attorney in Duke Law’s Wrongful Convictions Clinic. He received the Duke Law Clinics Advocacy Award for his work on behalf of a client who was exonerated after being wrongfully incarcerated for 23 years.
In college, Grady was a captain of the Oberlin College baseball team.
viewpoints
Courts Continue to Grapple with the Causation Standard for False Claims Act Suits Based on Alleged Kickback Schemes, While the Supreme Court Stays on the Sidelines
October 5, 2023 | Blog | By Brian Dunphy, Grady Campion, Melody Mathewson
A recent Massachusetts Federal District Court decision adds to divergent opinions deciding an important health care enforcement question: what causation standard applies to a False Claims Act (FCA) case based on a violation of the Anti-Kickback Statute (AKS)? The AKS states that a claim that includes items or services “resulting from” a violation of the AKS constitutes a “false or fraudulent claim” under the FCA. 42 U.S.C. § 1320a-7b(g). On September 27, 2023, Chief Judge Saylor of the District of Massachusetts issued a decision in United States v. Regeneron Pharmaceuticals, Inc., C.A No. 20-11217-FDS, which adopted a “but-for” standard of causation applicable to the AKS’s “resulting from” language.
Read more
The Sixth Circuit Adopts Narrow Interpretations of “Causation” and “Remuneration” for False Claims Act Suits Based on Alleged Kickback Schemes
April 6, 2023 | Blog | By Brian Dunphy, Grady Campion
EnforceMintz Newsletter — Health Care Enforcement Year In Review & 2023 Outlook
February 9, 2023 | Article | By Karen Lovitch, Brian Dunphy, Grady Campion, Kathryn Edgerton, Cory S. Flashner, Samantha Kingsbury, Kevin McGinty
The vast majority of False Claims Act recoveries in fiscal year 2022 came from health care–related cases, and new case filings remained high, despite an ongoing decline in health care FCA case volume. Mintz’s Health Care Enforcement Defense team explores FCA litigation trends using annual DOJ statistics and activity tracked in our database of health care whistleblower cases.
Read more
EnforceMintz — Despite Some Setbacks, Enforcement Authorities Continue to Focus on the Opioid Supply Chain
February 9, 2023 | Blog | By Grady Campion
Summer 2022: Key Trends in Pharmacy Enforcement Actions
August 29, 2022 | Blog | By Lauren Moldawer, Grady Campion, Pat Ouellette
Pharmacies have long been a focus of enforcement actions brought by the Department of Justice (DOJ) and Department of Health and Human Services Office of Inspector General (OIG). This summer has been no exception, with the DOJ and OIG bringing a number of fraud cases against pharmacies and pharmacists. We also saw enforcement against pharmacies for allegedly falsifying prior authorization information and providing more insulin than the pharmacy billed to payors. This blog summarizes some of these and other key pharmacy enforcement trends this summer.
Read more
Webinar Recording: Health Care Enforcement Year in Review & 2022 Outlook
February 16, 2022 | Webinar | By Grady Campion, Randy Jones, Samantha Kingsbury, Karen Lovitch, Kevin McGinty
In our annual webinar, Mintz’s Health Care Enforcement Defense team reviewed the key health care fraud enforcement developments and trends from 2021, assessed their likely impact in 2022, and provided recommendations to avoid government scrutiny.
Read more
Health Care Enforcement Year in Review & 2022 Outlook
February 11, 2022 |
In our annual Health Care Enforcement Year in Review & Outlook report, we examine the data and explore health care enforcement trends and likely targets of government scrutiny for 2022 and beyond.
Read more
Health Care Enforcement Update: Covid-19 Fraud Cases Brought By DOJ And Private Plaintiffs
March 31, 2021 | Blog | By Grady Campion, Jane Haviland, Karen Lovitch
On Friday, March 26, 2021, the Department of Justice (DOJ) announced an update on its efforts to combat COVID-19 related fraud. Since Congress first responded to the coronavirus pandemic by passing $2.2 trillion in relief through the Coronavirus Aid, Relief, and Economic Security (CARES) Act in March 2020, DOJ has pursued civil and criminal actions primarily targeting (1) fraudulent COVID-19 related tests or treatments, and (2) abuse of the CARES Act’s popular Paycheck Protection Program (PPP). Friday’s announcement revealed that DOJ is also ramping up its efforts to prosecute fraud on the CARES Act’s Economic Injury Disaster Loan (EIDL) and Unemployment Insurance (UI) initiatives.
Read more
The DOJ’s Fraud Section 2020 Annual Review: Financial Enforcement Focused on Major Corporate Resolutions and Emerging COVID-19 Fraud
March 12, 2021 | Blog | By Eoin Beirne, Grady Campion
Health Care Enforcement Kept the DOJ Fraud Section Busy in 2020
March 8, 2021 | Blog | By Eoin Beirne, Grady Campion
On February 24, 2021, DOJ’s Criminal Division Fraud Section published its annual year-end summary. The Fraud Section focuses on prosecuting white-collar crime. The report summarizes enforcement activity in the past year and discusses notable cases from the Fraud Section’s three litigation units: (1) the Health Care Fraud (HCF) Unit; (2) the Foreign Corrupt Practices Act (FCPA) Unit; and (3) the Market Integrity and Major Frauds (MIMF) Unit. In summarizing the Fraud Section’s main achievements from 2020, the report also provides valuable insights on what lies ahead for the Fraud Section in 2021. This post focuses on the health care enforcement portion of the Fraud Section’s report.
Read more
News & Press
Fifty-Nine Attorneys Recognized as 2023 Massachusetts Super Lawyers and Rising Stars
October 12, 2023
Mintz is pleased to announce that 32 attorneys have been named Massachusetts Super Lawyers and 27 attorneys have been named Massachusetts Rising Stars for 2023.
Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.
Healthcare Enforcement & Litigation 2022
August 27, 2021
Mintz Member and Chair of the firm’s Health Law and Health Care Enforcement Defense Practices Karen Lovitch, Member Laurence Freedman, Of Counsel Samantha Kingsbury, and Associates Grady Campion and Caitlin Hill co-authored the Global Overview and corresponding United States chapter of the seventh edition of Lexology’s Healthcare Enforcement & Litigation 2022. Together these pieces outlined federal enforcement priorities in 2020, including matters involving opioids, COVID-19-related fraud, Medicare, and more, and look ahead to how health care enforcement is expected to evolve in the coming year.
Events & Speaking
Speaker
Read less
Recognition & Awards
- Best Lawyers in America "Ones to Watch": Insurance Law (2024)
- Massachusetts Super Lawyers: Rising Star - Business Litigation (2023)
Recent Insights
Mintz is pleased to announce that 32 attorneys have been named Massachusetts Super Lawyers and 27 attorneys have been named Massachusetts Rising Stars for 2023.
Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.
